Therapeutic strategies to ameliorate lysosomal storage disorders – a focus on Gaucher disease

@article{Sawkar2005TherapeuticST,
  title={Therapeutic strategies to ameliorate lysosomal storage disorders – a focus on Gaucher disease},
  author={Anu R. Sawkar and Wim D’Haeze and Jeffery W Kelly},
  journal={Cellular and Molecular Life Sciences CMLS},
  year={2005},
  volume={63},
  pages={1179-1192}
}
The lysosomal storage disorders encompass more than 40 distinct diseases, most of which are caused by the deficient activity of a lysosomal hydrolase leading to the progressive, intralysosomal accumulation of substrates such as sphingolipids, mucopolysaccharides, and oligosaccharides. Here, we primarily focus on Gaucher disease, one of the most prevalent lysosomal storage disorders, which is caused by an impaired activity of glucocerebrosidase, resulting in the accumulation of the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 45 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 83 references

Gaucher diseaseassociated glucocerebrosidases show mutationdependent chemical chaperoning profiles

  • Zimmer K.-P., P. LeCoutre, G. AertsH.M.F., K. Harzer, M. Fukuda, S. O’BrienJ.
  • Chem . Biol .
  • 2005
1 Excerpt

Haemorheology in Gaucher disease

  • E. Beutler
  • Eur . J . Haematol .
  • 2005

Long - term expression of the human glucocerebrosidase gene in vivo after transplantation of bonemarrowderived cells transformed with a lentivirus vector

  • Y. KimE., B. HongY., Z. Lai, Cho Y.-H., O. BradyR., Jung S.-C.
  • J . Gene Med .
  • 2005

Similar Papers

Loading similar papers…